APP and Alzheimer disease: In addition to the characterization of MSC-exosomes, we used in vitro and in vivo assays; a human neural cell culture model consisting of a human neuroblastoma cell line overexpressing human APP with double FAD mutations and the J20 AD transgenic mouse model were employed for the evaluation of the abovementioned MSC-exosomes therapy.